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Abstract
Background: Prescription drugs account for approximately 11% of national health expenditures.
Prior research on adverse childhood experiences (ACEs), which include common forms of child
maltreatment and related traumatic stressors, has linked them to numerous health problems.
However, data about the relationship of these experiences to prescription drug use are scarce.
Method: We used the ACE Score (an integer count of 8 different categories of ACEs) as a
measure of cumulative exposure to traumatic stress during childhood. We prospectively assessed
the relationship of the Score to prescription drug use in a cohort of 15,033 adult HMO patients
(mean follow-up: 6.1 years) and assessed mediation of this relationship by documented ACE-
related health and social problems.
Results: Nearly 1.2 million prescriptions were recorded; prescriptions rates increased in a graded
fashion as the ACE Score increased (p for trend < 0.0001). Compared to persons with an ACE
Score of 0, persons with a Score ≥ 5 had rates increased by 40%; graded relationships were seen
for all age groups (18–44, 45–64, and 65–89 years) (p for trend < 0.01). Graded relationships were
observed for the risk of being in the upper decile of number of classes of drugs used; persons with
scores of ≥ 5 had this risk increased 2-fold. Adjustment for ACE-related health problems reduced
the strength of the associations by more than 60%.
Conclusion: ACEs substantially increase the number of prescriptions and classes of drugs used
for as long as 7 or 8 decades after their occurrence. The increases in prescription drug use were
largely mediated by documented ACE-related health and social problems.
Background
A growing body of literature suggests that child maltreat-
ment and traumatic stressors have long-term conse-
quences for adult health behavior and adult health
outcomes. Adults with a history of child maltreatment
have been shown to be at increased risk of multiple health
risk behaviors and risk factors for chronic disease includ-
ing overweight or obesity [1,2], smoking [3-5], and phys-
ical inactivity [6], and some have reported associations
with higher prevalences of heart [7-9], lung [10], and
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liver[11] disease, diabetes [9], and depression or depres-
sive disorders [12-17] – chronic conditions associated
with higher health care service utilization.
Health care resources are scarce, and therefore research
focused on explaining and/or predicting utilization of
health care services is both of interest and of importance
to policymakers. Use of prescription drugs, one of the
most rapidly growing sectors of health care in the US, has
increased substantially over the past 10 to 15 years,
although use of some prescription drugs, such as hor-
mone replacement therapy [18] and alpha- (α-) blockers
[19], has decreased. In 2000, three in five US adults filled
at least one prescription. [20] Nationally, the number of
purchased prescription drugs increased 75% between
1993 and 2005 from 2.0 to 3.5 billion per year. [21,22] In
2004 an estimated 45% of American adults were taking
prescription drugs on a regular basis and 27% were taking
them occasionally [23].
Increases in prescribed drug use are reflected in expendi-
tures for these medications. Spending on prescription
drugs in the United States in 2003 was nearly $180 bil-
lion, or 11% of total national health expenditures, and
was more than four times the amount spent on prescrip-
tion drugs in 1990.[24] Future spending on prescription
drugs is projected to increase 10.5% between 2005 and
2013, but this may turn out to be an underestimate as the
projection was made before the passage of the Medicare
Prescription Drug, Improvement, and Modernization Act
of 2003 [25].
Few studies have assessed the relationship of child mal-
treatment and related traumatic stressors to the use of pre-
scription drugs in adulthood. [26-29] Our earlier analyses
of data from the Adverse Childhood Experiences (ACE)
Study have demonstrated that an integer count of the
number of categories of abuse, exposure to domestic vio-
lence, and other forms of serious household dysfunction
(the ACE Score) [30] experienced during childhood has a
strong graded relationship to a wide variety of health and
social problems from adolescence to adulthood (Table 1).
[2,3,6,7,11,12,31-43] Therefore, we hypothesized that the
ACE Score would be associated with increased rates and
number of classes of prescriptions drugs used during an
average of 6.1 years of follow-up of adults in the ACE
Study cohort.
Methods
Study population
The ACE Study methods have been described in detail
elsewhere. [3,6,31] Briefly, more than 50,000 adult mem-
bers of the Kaiser Health Plan in San Diego, California are
evaluated annually for wellness care at Kaiser Perma-
nente's San Diego Health Appraisal Clinic (HAC) which
includes a standardized health history, psychosocial eval-
uations, and physical examination. Appointments for
most members are obtained by self-referral with 20%
referred by their health care provider. [6] A review of con-
tinuously enrolled (between 1992 and 1995) Kaiser Per-
manente members aged 25 years or older in San Diego
revealed that 81% of those members had been evaluated
at the Health Appraisal Clinic. [6] The ACE Study was
approved by the institutional review board of Kaiser Per-
manente and written informed consent was given by
study participants.
Within two weeks of their HAC visit, each member who
completed the standardized evaluation during the base-
line survey period (August 1995 to October 1997) was
mailed a study questionnaire that contained questions
about childhood exposure to abuse, neglect, domestic vio-
lence, and other forms of serious and interrelated house-
hold dysfunction. [30] A total of 17 421 (68%)
responded; 84 persons had incomplete information on
race and educational attainment leaving an analytic sam-
ple of 17 337 persons [32].
Table 1: Health and social problems shown to have a graded relationship to the ACE Score
Type of Problem Outcomes Associated with Adverse Childhood Experiences
Prevalent Diseases Ischemic heart disease6,7 cancer,6 chronic lung disease,6 skeletal fractures,6 sexually transmitted 
diseases,6,32,33 and liver disease6,11
Risk Factors for Common Diseases/Poor Health Smoking,3,6,31,32 alcohol abuse,12,31,32,34 promiscuity,6,31,32,35 obesity,2,6,31 illicit drug use,6,31,32,36 
injected drug use,6,31,36 multiple somatic symptoms,31 poor self-rated health,6 high perceived risk 
of AIDS35
Poor Mental Health Depressive disorders,6,31,32,37 anxiety,31 hallucinations,31,38 panic reactions,31 sleep disturbances,31 
memory disturbances,31,39 poor anger control,31 risk of perpetrating or being a victim of 
domestic violence31
Sexual and Reproductive Health Early age at first intercourse,31,35 sexual dissatisfaction,31 teen pregnancy,40 unintended 
pregnancy,41 teen paternity,42 fetal death40
General Health and Social Problems High perceived stress,31 difficulty with job performance,43 relationship problems,43 marriage to an 
alcoholic34
* A complete bibliography of ACE Study publications listed by topic area is available.57BMC Public Health 2008, 8:198 http://www.biomedcentral.com/1471-2458/8/198
Page 3 of 9
(page number not for citation purposes)
Eligibility for the Prospective (Follow-up) Phase of the 
Study
Follow-up data on the use of prescription drugs was avail-
able from Kaiser Permanente from January 1, 1997
through December 31, 2004. We excluded 18 persons
aged 90 years or older to facilitate direct age standardiza-
tion to the 2000 US population. We also excluded 1053
(6%) persons whose membership had lapsed prior to
their evaluation at the HAC or before January 1, 1997 or
whose member record number was not considered valid.
In addition, among persons who disenrolled and reen-
rolled at least once (median/mean: 1 time; range: 1–6
times) during the follow-up period, we excluded the 1233
(7%) persons whose ratio of time disenrolled/total possi-
ble time enrolled during follow-up exceeded 20%; we
considered such persons to have inadequate continuity of
follow-up to merit inclusion in the prospective analysis.
Thus, the final sample retained 15 033 of the 17 337 per-
sons included in the baseline survey (87%).
Table 2: Definition and prevalence of each category of adverse childhood experience
Childhood Abuse
Emotional 10.3%
(Did a parent or other adult in the household.....)
1) Often or very often swear at you, insult you, or put you down?
2) Sometimes, often, or very often act in a way that made you that you might be physically hurt?
Physical 28.0%
(Did a parent or other adult in the household.....)
1) Often or very often push, grab, slap, or throw something at you?
2) Often or very often hit you so hard that you had marks or were injured?
Sexual 20.4%
(Did an adult or person at least 5 years older ever.....)
1) Touch or fondle you in a sexual way?
2) Have you touch their body in a sexual way?
3) Attempt oral, anal, or vaginal intercourse with you?
4) Actually have oral, anal, or vaginal intercourse with you?
Household dysfunction
Substance abuse 26.6%
1) Live with anyone who was a problem drinker or alcoholic?
2) Live with anyone who used street drugs?
Mental Illness 19.0%
1) Was a household member depressed or mentally ill?
2) Did a household member attempt suicide?
Mother treated violently 12.6%
(Was your mother (or stepmother)):
1) Sometimes, often, or very often pushed, grabbed, slapped, or had something thrown at her?
2) Sometimes, often, or very often kicked, bitten, hit with a fist, or hit with something hard?
3) Ever repeatedly hit over at least a few minutes?
4) Ever threatened with or hurt by a knife or gun?
Incarcerated household member 4.5%
1) Did a household member go to prison?
Parental separation or divorce 22.8%
1) Were your parents ever separated or divorced?
Number of adverse childhood experiences (ACE Score)
0 36.4%
1 26.2%
2 15.9%
3 9.3%
4 6.1%
5 or more 6.1%
* Percentages based on a total of 15,033 adults included in the analysis sampleBMC Public Health 2008, 8:198 http://www.biomedcentral.com/1471-2458/8/198
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To assess any influence of including persons with discon-
tinuous follow-up who had a ratio as described of (≤
20%), we repeated the analyses included herein after
excluding any persons whose follow-up was discontinu-
ous.
Relationship of the ACE Score to Exclusion from Follow-up
We used logistic regression to assess the probability that
the ACE Score might be related to excluding from follow-
up. In this analysis, the risks (ORs) of exclusion from fol-
low-up for persons with 1, 2, 3, or ≥ 4 ACEs were 1.0 (0.9–
1.1), 1.0 (0.9–1.2), 1.2 (1.0–1.4) and 1.1 (0.9–1.3),
respectively, and thus we ruled out exclusion from follow-
up as a potential source of bias.
Definitions of Adverse Childhood Experiences (ACEs)
All questions used to define ACEs pertained to the
respondents' first 18 years of life (≤ 18 years of age) (Table
2). Questions adapted from the Conflict Tactics Scale
(CTS) [44] had 5 response categories: "never", "once or
twice", "sometimes", "often", or "very often". We defined
3 types of childhood abuse: emotional abuse (2 ques-
tions), physical abuse (2 questions), or contact sexual
abuse (4 questions) by Wyatt. [45] We also defined 5
exposures to household dysfunction during childhood:
exposure to substance abuse (defined by 2 questions)
[46], mental illness (2 questions), violent treatment of
mother or stepmother (4 questions) [44], criminal behav-
ior in the household (1 question), and parental separa-
tion or divorce (1 question). Respondents were defined as
exposed to a category if they responded "yes" to 1 or more
of the questions in that category.
To assess the cumulative effect of early trauma and stress
on use of prescription drugs, the total number of these cat-
egories of childhood exposures (range: 0–8) was summed
to create the ACE Score (Table 2). The statistical character-
istics and validity of the ACE Score have been published
elsewhere [30].
Rates of Prescription Drug Use
To calculate rates of prescription drug use, we divided
total claims for prescription drugs by the cumulative per-
son-time at risk during follow-up. Person-time at risk was
calculated using electronic enrollment data files provided
by Kaiser Permanente. Because pharmacy claims data
were not available before January 1, 1997, we designated
this date as beginning of follow-up for persons enrolled
before January 1, 1997. We counted prescription medica-
tions through December 31, 2004 (latest available data).
We calculated the maximum possible person-time at risk
as the difference between December 31, 2004 and the
later of either January 1, 1997 or the baseline appoint-
ment date for persons who were continuously enrolled.
For persons with periods of disenrollment from their
baseline appointment date to December 31, 2004, follow-
up time was calculated as the maximum possible person-
time less periods of disenrollment.
Use of Multiple Classes of Prescription Drugs
The Kaiser pharmacy database includes 15 classes of
drugs: anti-infectives, endocrine and metabolic, cardio-
vascular, respiratory, gastrointestinal, genitourinary, cen-
tral nervous system, analgesics and anesthetics,
neuromuscular, topical products, biologics, antineoplas-
tics, nutritional, hematological agents, and other drugs.
On an a priori basis we chose the approximate age-specific
upper decile of the number of classes of prescription drugs
used during follow-up to define persons as having used
multiple classes of pharmaceuticals. The approximate
upper deciles for the age groups 18–44 years, 45–64 years,
and 65–89 years were 8, 10, and 11, respectively; the prev-
alence of persons in each of these age-specific groups was
17%, 12%, and 15%, respectively (total = 14%).
Statistical Analysis
Analyses were completed using SAS v8.2 (SAS Institute,
Cary, NC). [47] We used the 2000 US Standard Popula-
tion for direct age-standardization of prevalences and
risks.
To assess the independent relationship between the ACE
Score and the rate of prescription drug use, we used rate
ratios derived from multivariable-adjusted negative bino-
mial regression models employing PROC GENMOD. [47]
To allow for differing lengths of follow-up, the log of per-
son-time was incorporated as the offset in the model. Rate
ratios were obtained by exponentiating estimated regres-
sion coefficients. Age, race/ethnicity, educational attain-
ment and sex were forced into all models.
We used multivariable adjusted logistic regression to
assess the relationship of the ACE Score to prescription of
multiple classes of drugs and included the following cov-
ariates: age at baseline, sex, race (white, nonwhite), and
education (< high school, high school, some college, col-
lege graduate). All statistical inferences were based on a
significance level of α (2-sided) = 0.05.
Assessment of Mediation by Documented ACE-related 
Health and Social Problems
Previously, we have reported graded relationships
between the ACE Score and multiple health and social
outcomes (Table 1) that ultimately lead a physician to
prescribe medication. Therefore, we hypothesized that the
presence of these conditions would mediate the relation-
ship of the ACE Score to use of prescription pharmaceuti-
cals. To examine this issue, we used logistic regression
models without (Model A) and with (Model B) each ofBMC Public Health 2008, 8:198 http://www.biomedcentral.com/1471-2458/8/198
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the health and social problems from Table 1 (coded
dichotomously (yes/no). We compared the reduction in
the strength of the relationship (odds ratio) between
Model A and Model B using the risk decrement which was
expressed as a percent and calculated as follows:
Results
Characteristics of Study Population
The study population included 8134 women (54%) and
6899 men (46%). The mean age (standard deviation) was
57 (15) years. Seventy-six percent were white, 11% His-
panic, 4% Black, 7% Asian, < 1% Native American, and
2% other; 40% were college graduates; 36% had some col-
lege education; and 17% were high school graduates.
Only 7% had not graduated from high school. The mean
length of follow-up was 6.1 (SD, 2.4) years.
The prevalence of each of the 8 individual ACEs and the
ACE Score are presented in Table 2. A total of 1 188 052
prescriptions were written during 95 883 person-years of
follow-up. The age-standardized prescription rate was 9.6
per person-year (data not shown).
Prescription Rates by ACE Score
As the ACE Score increased, rates of prescription drug use
increased in a graded fashion (Table 3). This relationship
was graded for each age group but was attenuated among
persons 65–89 years. However, the trend was statistically
significant for all age groups (Table 3).
Risk of Being Prescribed Multiple Classes of Drugs
As the ACE Score increased, the risk (adjusted odds ratio)
of having been prescribed multiple classes of pharmaceu-
ticals also increased in a graded fashion for all age groups
(Table 4).
Relationship Between Prescription Rates and Multiple 
Classes Drugs Used
As the number of classes of drugs used increased, the
number of prescriptions also increased (Pearsons correla-
tion = .69; p < 0.001). Both the mean and the median
rates of prescriptions increased dramatically as the
number of classes increased from 0 to 14 (data not
shown).
Mediation by ACE-related Health and Social Problems
For persons of all ages, the ACE Score had a graded rela-
tionship to rates of prescription drug use (Table 5); for
persons with ACE Scores ≥ 5, the rate increased by more
than 40% (Table 5). When we entered the variables for the
health and social problems (Table 1) into a model for
rates of prescriptions, the relative rates were reduced for
each level of the ACE Score; these reductions ranged from
67–70% (median, 69%)(Table 5).
Similarly, for persons of all ages, the risk of being pre-
scribed multiple classes drugs increased in a graded fash-
ion as the ACE Score increased (Model A, Table 5); for
persons with ACE Scores s805; 5, the risk was increased 2-
fold. Entry of the ACE-related health problems into this
model reduced the risks (ORs) by 26–67% (median:
61%).
Discussion
In this large study of HMO patients we found that rates of
prescriptions increased in a graded fashion as the ACE
Score increased. This pattern was particularly evident in
the younger age groups – whose rates were increased by as
much as 60% for persons with ACE Scores of 5 or more.
Previous research has shown ACEs to be associated with
earlier onsets of health risks such as smoking [3], alcohol
[34] and illicit drug use [36], and sexual intercourse.
[31,35] Thus, ACEs may "accelerate" the onset of health
risks and illnesses, in the process increasing the use of pre-
scription drugs among younger persons. If this is the case,
the greatest relative effects on prescription rates would be
expected among younger persons.
Model A odds ratio Model B odds ratio
Model A odds ratio 1 
−
−
× ×100.
Table 3: Prescription drug rates (per person per year) by age group and ACE Score
Age 18–44 years Age 45–64 years Age 65–89 years
ACE Score Rate RR* (95% CI) Rate RR* (95% CI) Rate RR* (95% CI)
0 5.03 1.00 (referent) 10.18 1.00 (referent) 17.27 1.00 (referent)
1 5.99 1.14 (1.00–1.29) 11.19 1.09 (1.02–1.17) 16.92 0.99 (0.94–1.05)
2 6.86 1.30 (1.13–1.50) 11.33 1.12 (1.04–1.21) 18.10 1.08 (1.00–1.16)
3 6.95 1.33 (1.13–1.56) 12.11 1.17 (1.06–1.28) 17.83 1.04 (0.93–1.15)
4 7.64 1.46 (1.23–1.73) 12.59 1.24 (1.11–1.39) 19.43 1.12 (0.98–1.29)
5 or more 8.84 1.63 (1.38–1.93) 15.48 1.45 (1.30–1.62) 20.67 1.25 (1.05–1.48)
Overall 6.45 11.32 17.47
p-value, trend < 0.0001 < 0.0001 0.0025
* Relative rate (RR) and 95% confidence interval (CI) adjusted for age, sex, race, educationBMC Public Health 2008, 8:198 http://www.biomedcentral.com/1471-2458/8/198
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Among older persons, the graded relationship between
the ACE Score and prescription rates was attenuated. This
could be due to differential morbidity and mortality
because ACEs influence a multitude of health and social
problems (Table 1). Older persons affected by ACEs might
expectedly have higher levels of multimorbidity [31] or
severe health problems (such as ischemic heart disease [7]
or liver disease [11]), requiring ongoing specialty care. In
this scenario, older persons would be less likely to visit a
clinic for wellness care and hence, less likely to have
enrolled in the study. Moreover, ACE Scores tend to be
lower among older persons, [6] possibly as a result of
increased mortality over time leading to a decreased like-
lihood that persons with high levels of ACEs would sur-
vive to be in the older age groups included in the study.
Our finding that the risk of being prescribed multiple
classes of drugs during follow-up increased in a strong
graded fashion as the ACE Score increased lends further
support for the idea that ACEs matter long after they
occur. We found a 2-fold increase for young and middle-
aged persons and 1.7-fold for the older persons with
Scores ≥ 5. Thus, there was little evidence of attenuation
among older persons as was observed for rates of prescrip-
tion use. This is likely due to the choice of the upper decile
of number of drug classes – an extreme measure – which
may have selected persons with comorbid conditions that
resulted from exposure to ACEs. We have previously
shown that the mean number of a variety of health-related
problems [31] and the number of risk factors for the lead-
ing causes of death increases as the ACE Score increases
[6].
When we controlled for documented ACE-related health
and social problems (Table 1), the apparent effects of
ACEs on rates of prescription drug use were reduced by
67–76% (median, (69%); similarly, the risk of using a
high number of classes of drugs during follow-up was
reduced by 26–67% (median, 61%). Thus, as would be
expected, the documented ACE-related conditions among
participants appear to account for the majority, although
not all, of the increase use of prescription medications we
observed. Because screening for childhood traumatic
stressors is not yet a routine part of adult medical care,
some clinicians are likely identifying and treating these
conditions without a full understanding of their origins in
the long-term neurobiologic effects [31,48,49] of child-
hood stressors.
Relationships between child maltreatment and prescrip-
tion drug use in adulthood among adult survivors of child
maltreatment have been examined previously, but the
relationships remain unclear as studies are often limited
by study design, use of clinical populations versus com-
munity-based samples, self-reported health care service
utilization measures, examination of only one or two
types of maltreatment, and suboptimal statistical analyses
as in the case of no multivariable adjustment of compari-
sons. In our study, the multivariable-adjusted relative rate
of prescriptions as well as the relative risk of use of a high
number of classes of drugs increased with a higher ACE
Score. In a study of 3333 women aged 18–64 years who
were members of a large health maintenance organization
in the northwestern United States, Bonomi and collegues
[26] observed that women with a history of both physical
and sexual childhood abuse had more pharmacy fills
(adjusted incidence rate ratio = 1.57; 95% CI: 1.33–1.86)
than women without a history of child physical or sexual
abuse. In a study of 150 women aged 17–49 years seen
consecutively for non-emergency medical care by a family
practitioner in a health maintenance organization, San-
sone and colleagues [29] found a significant association
between sexual abuse and the number of prescribed med-
ications, obtained from a physician review of patient
medical records, during the 12-months following comple-
tion of a clinic survey; lifetime physical or emotional
abuse were not associated with use. Participants were not
queried for abuse that occurred only during childhood;
rather, for each type of abuse participants provided an age
range during which the event(s) occurred.
Table 4: Prevalence of multiple prescription medication classes (upper decile by age) during follow-up by age group and ACE Score
Age 18–44 years Age 45–64 years Age 65–89 years
ACE Score Top 10% (%) OR* (95% CI) Top 10% (%) OR* (95% CI) Top 10% (%) OR* (95% CI)
0 12.67 1.00 (referent) 10.14 1.00 (referent) 14.06 1.00 (referent)
1 16.27 1.39 (1.06–1.82) 11.51 1.14 (0.93–1.41) 15.14 1.14 (0.94–1.39)
2 17.54 1.53 (1.14–2.04) 12.08 1.21 (0.96–1.53) 14.56 1.11 (0.87–1.43)
3 18.42 1.51 (1.09–2.09) 13.44 1.38 (1.05–1.80) 16.72 1.26 (0.90–1.76)
4 18.48 1.47 (1.04–2.07) 16.38 1.65 (1.22–2.24) 22.42 1.83 (1.24–2.72)
5 or more 25.27 2.11 (1.54–2.89) 21.52 2.22 (1.68–2.92) 19.23 1.56 (0.93–2.60)
Overall 16.97 12.31 14.98
p-value, trend < 0.0001 < 0.0001 0.0020
* Odds ratio (OR) and 95% confidence interval (CI) adjusted for age, sex, race, educationBMC Public Health 2008, 8:198 http://www.biomedcentral.com/1471-2458/8/198
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Using data from women members of a health mainte-
nance organization, Farley and Patsalides [27] report sig-
nificantly more prescription medications obtained from
medical record review among women with a history of
childhood physical and sexual abuse (n = 27) compared
to women without a history of either form of abuse (n =
26). The study is limited by a low response rate (14%) for
the mailed survey, the absence of any quantitative data on
the prescription drug use, and the absence of any multi-
variable adjustment in the statistical comparisons of
abuse groups. In a clinical sample of 75 women with
fibromyalgia, Alexander and associates [28] observed an
increased use of pain medications and greater outpatient
service use among women with a history of sexual or
physical abuse compared to those without such a history.
The study did not stipulate when the abuse occurred (i.e.,
childhood or adolescence vs adulthood) and did not
include multivariable-adjusted statistical analyses.
The analyses herein have several strengths. Prescriptions
were obtained prospectively from electronic, administra-
tive pharmacy claims data and therefore are not subject to
differential misreporting. The relationship of ACEs to pre-
scription drug use is not limited to any specific class of
drugs (data not shown). Future analyses will detail the
relationship of ACEs to increased use of individual classes
of drugs.
Our results should be interpreted keeping the following
limitations in mind. Because of the sensitive nature of
questions about ACEs and affective problems, the
responses probably represent an underreporting of their
actual occurrence. However, our estimates of the preva-
lence of childhood exposures are similar to estimates from
nationally representative surveys [50,51] indicating that
the experiences of our participants are comparable to
those of the larger population of adults. For example, in
our study we found that 16% of the men and 25% of the
women met the case definition for contact sexual abuse; a
national telephone survey of adults conducted by Finkel-
hor and colleagues [52] using similar criteria for sexual
abuse estimated that 16% of men and 27% of women had
been sexually abused. Of the men in our study, 28% had
been physically abused as boys, which closely parallels the
percentage (31%) found in a population-based study of
men in Ontario that used questions from the same scales.
[53] The similarity in estimates of the prevalence of these
childhood exposures between the ACE Study and other
Table 5: Rates of prescription drugs and risk (odds ratio) of multiple classes prescribed by ACE Score with and without adjustment for 
potential mediating health-related conditions shown to have a graded relationship to the ACE Score
Prescription drug rates
ACE Score Rate PPPY* Model A RR† (95% CI) Model B RR‡ (95% CI) % Decrease due to mediation
0 8.41 1.00 (referent) 1.00 (referent) ···
1 9.40 1.06 (1.01–1.11) 1.02 (0.98–1.07) 67
2 9.96 1.13 (1.07–1.19) 1.04 (0.99–1.10) 69
3 10.28 1.15 (1.08–1.23) 1.05 (0.99–1.12) 67
4 11.58 1.25 (1.16–1.35) 1.06 (0.98–1.15) 76
5 or more 12.05 1.44 (1.33–1.56) 1.13 (1.05–1.23) 70
Overall 9.59
p-value, trend < 0.0001 0.0016 Median = 69
Multiple prescription medication classes
ACE Score Proportion in Top Decile* Model A OR† (95% CI) Model B OR‡ (95% CI) % Decrease due to mediation
0 10.84 1.00 (referent) 1.00 (referent) ···
1 13.49 1.19 (1.05–1.35) 1.14 (1.00–1.29) 26
2 14.19 1.24 (1.08–1.43) 1.08 (0.93–1.26) 67
3 15.70 1.33 (1.13–1.58) 1.11 (0.93–1.33) 67
4 17.76 1.57 (1.30–1.90) 1.22 (1.00–1.50) 61
5 or more 20.71 2.00 (1.67–2.40) 1.41 (1.15–1.73) 59
Overall 14.05
p-value, trend < 0.0001 0.0026 Median = 61
PPPY, per person per year
* Age standardized using the method of direct standardization and the 2000 US standard population
† Adjusted for age, sex, race, education
‡ Adjusted for age, sex, race, education, and all documented health-related problems shown to have a graded relationship to the ACE Score (see 
Table 1)BMC Public Health 2008, 8:198 http://www.biomedcentral.com/1471-2458/8/198
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population-based studies suggests that our findings are
likely to be applicable in other settings. Also, when utiliz-
ing retrospective reports of adverse childhood experi-
ences, several factors may inevitably lead to variability in
the responses over time. These include difficulty recalling
the experiences the due to the time lapse between the
events in question and the research survey, variability in
responses may occur due to the sensitive nature of the
questions and the subjects' knowledge of the "social
taboos" of responding to such questions, and incomplete
or total inability to recall the experiences due to memory
impairments as a result of stressful childhood experiences.
Dube and associates [54] observed that retrospective
responses to childhood abuse and related forms of serious
household dysfunction are generally stable over time con-
cluding that there is good to excellent reliability in the
reports of adverse childhood experiences during adult-
hood.
Conclusion
The mind-body dichotomy that persists in Western medi-
cal training may lead clinicians away from understanding
the role that childhood trauma and stress has on the
health of their adult patients. Childhood stressors are
known to produce changes in the developing brain that
affect emotions, behavior, and cognition [55] which in
turn can impair health and quality of life via numerous
pathways (Table 1). These traumatic pathophysiological
insults may be "silent" until much later in life, [55,56]
leading clinicians to prescribe medications to treat symp-
toms and illnesses without knowledge of their potential
origins in the disruptive effects of ACEs on neurodevelop-
ment. As improvements in the treatment of persons
affected by traumatic stress evolve, understanding the role
of these childhood experiences on adult health will
become increasingly important in making decisions
about prognosis, diagnosis, and treatment.
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